Skip to main content

PROVINCIAL DRUG COVERAGE – ONTARIO

AS OF January 2025

Coverage is under constant review and is subject to change.

Access to a generic or biosimilar equivalent is generally reported to be identical to that of the relevant brand name medication.

TYPE OF LISTING

ONTARIO COVERAGE

Bisphosphonates

Etidronate

Didronel; Generics Available

Not in Drug Formulary

Alendronate

Fosamax; Generics Available

Regular Benefit (10mg Generics, 70mg Generics);

Limited Coverage (Fosamax 70 mg);


Non-Benefit (Fosamax 10mg, All 5mg)

Fosavance; Generics Available

Regular Benefit (Generics);
Limited Coverage (Fosavance)

Risedronate

Actonel; Generics Available

Regular Benefit (5mg Generics, All 30mg, All 35mg, All 150mg);

Limited Coverage (Actonel 150mg);

Non-Benefit (Actonel 5mg, Actonel 30mg)

Actonel; DR

Regular Benefit (Generics);
Limited Coverage (Actonel DR)

Zoledronic Acid

Aclasta; Generics Available

Regular Benefit (4mg inj Generics except Zometa Concentrate);
Limited Coverage (5mg inj)

SERMs

Raloxifene

Evista; Generics Available

Limited Coverage

Teriparatide (PTH)

Forteo; Generics Available

Limited Coverage

Osnuvo (biosimilar)

Limited Coverage

Denosumab

Prolia

Limited Coverage

Jubbonti (biosimilar)

Limited Coverage

Romosozumab

Evenity

Limited Coverage

© Osteoporosis Canada, 2025
Charitable Registration No. 89551 0931 RR 0001